Evidence map›Paper›PMID 42868088›Full record

ArticleBJS open2026

Elective cholecystectomy benchmarks: nationwide registry study.

Ebba Kihlstedt Pasquier, Ellen Andersson, Johanna Österberg, Per Sandström, Bergthor Björnsson

Abstract read
In one paragraph

Article in BJS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ebba Kihlstedt PasquierDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0002-5754-3271
Ellen AnderssonDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-6533-8166
Johanna ÖsterbergDepartment of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Per SandströmDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Bergthor BjörnssonDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-9704-1260

Funding

Lion
6 · The paper itself

Abstract

backgroundLaparoscopic cholecystectomy is the treatment of choice for symptomatic gallstone disease. The aim of this study was to establish clinically relevant benchmarks for elective laparoscopic cholecystectomy (ELC) to guide quality initiatives and support improvements in patient outcomes.

methodThe Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography provided data on patients treated with primary ELC for a benign indication between 2015 and 2023. Exclusion criteria were common bile duct stones or stents detected before surgery, suspicion of bile duct obstruction, abnormal or unperformed intraoperative cholangiogram, previous major upper abdominal surgery, concomitant surgical procedures, and robotic surgery. The Achievable Benchmark of Care methodology was used to develop intra- and postoperative benchmarks, with severe postoperative complications (Clavien-Dindo ≥ III) representing the primary outcome. During surgery, serious adverse events were defined as intestinal perforation, bile leakage, or bleeding requiring transfusion or conversion to open surgery. Postoperative outcomes were assessed up to 30 days after surgery. Logistic regression identified risk factors for severe postoperative complications.

resultsOverall, 48 564 patients undergoing ELCs across 81 surgical facilities were included. Among these, 69% were women. Median age was 50 (range 18-95) years and 91.4% were classified as American Society of Anesthesiologists classification ≤ II. Ten benchmarks were developed, capturing either intraoperative events (3) or postoperative complications (7). During surgery, 0.5% of the total cohort experienced a serious adverse event (median 0.3%, interquartile range 0.2-0.7% between facilities)-benchmark was 0.2%. Severe postoperative complications occurred in 1.7% of patients (median 1.6%, interquartile range 1.0-2.2% between facilities)-benchmark was 1.0%. Postoperative mortality was low (7 deaths, < 0.1%). At multivariable analysis, American Society of Anesthesiologists classification ≥ III (odds ratio 1.35, 95% confidence interval 1.05 to 1.72; P = 0.018), previous abdominal surgery (odds ratio 2.15, 1.24 to 3.75; P = 0.007), and intraoperative assessment of an altered gallbladder morphology (odds ratio 1.24, 1.01 to 1.52; P = 0.044) were independently associated with severe postoperative complications.

conclusionThis study provides benchmarks for elective laparoscopic cholecystectomy. When compared with real-world performance, these benchmarks highlight potential areas for quality improvement.

Indexed as

BenchmarkingCholecystectomy, LaparoscopicElective Surgical ProceduresGallstonesPostoperative ComplicationsAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRegistriesRisk FactorsSwedenbenchmarkingGallRiks registrylaparoscopyquality improvementsurgical outcomes

Identifiers

PMID42868088
PMCPMC13660693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.